AAAAAA
Results: 1-25/444
Authors:
COOPER AJ
CARROLL CB
MITCHELL IJ
Citation: Aj. Cooper et al., GLUTAMATE ANTAGONISTS FOR PARKINSONS-DISEASE - RATIONALE FOR USE AND THERAPEUTIC IMPLICATIONS, CNS DRUGS, 9(6), 1998, pp. 421-429
Authors:
WHEATLEY D
Citation: D. Wheatley, HYPERICUM EXTRACT - POTENTIAL IN THE TREATMENT OF DEPRESSION, CNS DRUGS, 9(6), 1998, pp. 431-440
Authors:
NEWBURN G
Citation: G. Newburn, PSYCHIATRIC-DISORDERS ASSOCIATED WITH TRAUMATIC BRAIN INJURY - OPTIMAL TREATMENT, CNS DRUGS, 9(6), 1998, pp. 441-456
Authors:
BREEN R
THORNHILL JT
Citation: R. Breen et Jt. Thornhill, NONCOMPLIANCE WITH MEDICATION FOR PSYCHIATRIC-DISORDERS - REASONS ANDREMEDIES, CNS DRUGS, 9(6), 1998, pp. 457-471
Authors:
BLUNDELL JE
HALFORD JCG
Citation: Je. Blundell et Jcg. Halford, SEROTONIN AND APPETITE REGULATION - IMPLICATIONS FOR THE PHARMACOLOGICAL TREATMENT OF OBESITY, CNS DRUGS, 9(6), 1998, pp. 473-495
Authors:
NOBLE S
BENFIELD P
Citation: S. Noble et P. Benfield, PIRACETAM - A REVIEW OF ITS CLINICAL POTENTIAL IN THE MANAGEMENT OF PATIENTS WITH STROKE, CNS DRUGS, 9(6), 1998, pp. 497-511
Authors:
BEASLEY CM
Citation: Cm. Beasley, SUICIDALITY WITH FLUOXETINE, CNS DRUGS, 9(6), 1998, pp. 513-514
Authors:
BOND AJ
Citation: Aj. Bond, SUICIDALITY WITH FLUOXETINE - REPLY, CNS DRUGS, 9(6), 1998, pp. 514-515
Authors:
BENAVENTE O
SHERMAN DG
Citation: O. Benavente et Dg. Sherman, THERAPEUTIC POTENTIAL OF ANCROD IN THE MANAGEMENT OF CEREBROVASCULAR DISORDERS, CNS DRUGS, 9(5), 1998, pp. 341-346
Authors:
WILENS TE
BIEDERMAN J
SPENCER TJ
Citation: Te. Wilens et al., PHARMACOTHERAPY OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN ADULTS, CNS DRUGS, 9(5), 1998, pp. 347-356
Authors:
MESCHIA JF
BRUNO A
Citation: Jf. Meschia et A. Bruno, POSTSTROKE COMPLICATIONS - EPIDEMIOLOGY AND PROSPECTS FOR PHARMACOLOGICAL INTERVENTION DURING REHABILITATION, CNS DRUGS, 9(5), 1998, pp. 357-370
Authors:
WEINER DM
LOWE FC
Citation: Dm. Weiner et Fc. Lowe, PSYCHOTROPIC DRUG-INDUCED PRIAPISM - INCIDENCE, MECHANISM AND MANAGEMENT, CNS DRUGS, 9(5), 1998, pp. 371-379
Authors:
ZUMBRUNNEN TL
JANN MW
Citation: Tl. Zumbrunnen et Mw. Jann, DRUG-INTERACTIONS WITH ANTIPSYCHOTIC AGENTS - INCIDENCE AND THERAPEUTIC IMPLICATIONS, CNS DRUGS, 9(5), 1998, pp. 381-401
Authors:
ADKINS JC
NOBLE S
Citation: Jc. Adkins et S. Noble, IDEBENONE - A REVIEW OF ITS USE IN MILD-TO-MODERATE ALZHEIMERS-DISEASE, CNS DRUGS, 9(5), 1998, pp. 403-419
Authors:
PANG K
INGOLIA TD
Citation: K. Pang et Td. Ingolia, SONIC HEDGEHOG PROTEIN - A NOVEL-APPROACH TO THE TREATMENT OF NEURODEGENERATIVE DISORDERS, CNS DRUGS, 9(4), 1998, pp. 253-259
Authors:
YONKERS KA
LITTLE BB
MARCH D
Citation: Ka. Yonkers et al., LITHIUM DURING PREGNANCY - DRUG EFFECTS AND THEIR THERAPEUTIC IMPLICATIONS, CNS DRUGS, 9(4), 1998, pp. 261-269
Authors:
BAKISH D
HABIB R
HOOPER CL
Citation: D. Bakish et al., MIXED ANXIETY AND DEPRESSION - DIAGNOSIS AND TREATMENT OPTIONS, CNS DRUGS, 9(4), 1998, pp. 271-280
Authors:
MARKHAM A
BENFIELD P
Citation: A. Markham et P. Benfield, PERGOLIDE - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE IN PARKINSONS-DISEASE. (VOL 7, PG 328, 1997), CNS DRUGS, 9(4), 1998, pp. 280-280
Authors:
DAVIS R
MARKHAM A
Citation: R. Davis et A. Markham, ZIPRASIDONE (VOL 8, PG 153, 1997), CNS DRUGS, 9(4), 1998, pp. 280-280
Authors:
PRAKASH A
LAMB HM
Citation: A. Prakash et Hm. Lamb, ZOTEPINE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF SCHIZOPHRENIA (VOL 9, PG 153, 1998), CNS DRUGS, 9(4), 1998, pp. 280-280
Authors:
MORGAN A
CLARK D
Citation: A. Morgan et D. Clark, CNS ADVERSE-EFFECTS OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - THERAPEUTIC IMPLICATIONS, CNS DRUGS, 9(4), 1998, pp. 281-290
Authors:
DALVI A
FORD B
Citation: A. Dalvi et B. Ford, ANTIPARKINSONIAN AGENTS - CLINICALLY SIGNIFICANT DRUG-INTERACTIONS AND ADVERSE-EFFECTS, AND THEIR MANAGEMENT, CNS DRUGS, 9(4), 1998, pp. 291-310
Authors:
MCCLELLAN KJ
SPENCER CM
Citation: Kj. Mcclellan et Cm. Spencer, MODAFINIL - A REVIEW OF ITS PHARMACOLOGY AND CLINICAL EFFICACY IN THEMANAGEMENT OF NARCOLEPSY, CNS DRUGS, 9(4), 1998, pp. 311-324
Authors:
GUNASEKARA NS
SPENCER CM
Citation: Ns. Gunasekara et Cm. Spencer, QUETIAPINE - A REVIEW OF ITS USE IN SCHIZOPHRENIA, CNS DRUGS, 9(4), 1998, pp. 325-340
Authors:
STASSEN HH
ANGST J
Citation: Hh. Stassen et J. Angst, DELAYED-ONSET OF ACTION OF ANTIDEPRESSANTS - FACT OR FICTION, CNS DRUGS, 9(3), 1998, pp. 177-184